BioRem Inc. (TSXV:BRM)
Canada flag Canada · Delayed Price · Currency is CAD
3.270
+0.070 (2.19%)
May 1, 2026, 3:59 PM EST

BioRem Cash Flow Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
4.823.042.181.611.3
Depreciation & Amortization
0.470.470.380.350.34
Stock-Based Compensation
0.060.140.130.090.01
Other Adjustments
0.650.470.540.120.43
Change in Receivables
-0.640.24-3.04-1.72-2.53
Changes in Inventories
1.42-1.83-0.040.250.04
Changes in Accounts Payable
4.13-2.521.380.743.25
Changes in Accrued Expenses
-0.560.23-0.460.060.32
Changes in Income Taxes Payable
-0.070.75-0.70.350.3
Changes in Unearned Revenue
-1.71.841.81-0.550.24
Changes in Other Operating Activities
-0.930.84-1.690.140.06
Operating Cash Flow
7.643.690.491.443.78
Operating Cash Flow Growth
107.28%652.01%-66.09%-61.79%13.11%
Capital Expenditures
-0.37-0.37-0.55-0.2-0.08
Investing Cash Flow
-0.37-0.37-0.55-0.2-0.08
Short-Term Debt Issued
----1.01
Short-Term Debt Repaid
---0.78-0.23-
Net Short-Term Debt Issued (Repaid)
---0.78-0.231.01
Long-Term Debt Issued
----4
Long-Term Debt Repaid
-0.57-0.55-0.53-0.5-
Net Long-Term Debt Issued (Repaid)
-0.57-0.55-0.53-0.54
Issuance of Common Stock
0.020.160.0700.08
Repurchase of Common Stock
-0.1----12.41
Net Common Stock Issued (Repurchased)
-0.080.160.070-12.33
Other Financing Activities
-0.11-0.18-0.1-0.22-0.24
Financing Cash Flow
-0.77-0.57-1.33-0.95-7.56
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-0.210.18-0.09-0.99-0.55
Net Cash Flow
6.292.92-1.48-0.7-4.4
Free Cash Flow
7.273.31-0.061.243.71
Free Cash Flow Growth
119.45%---66.50%23.48%
FCF Margin
17.17%8.85%-0.25%4.30%15.14%
Free Cash Flow Per Share
0.390.18-0.000.070.10
Levered Free Cash Flow
6.631.9212.0110.8
Unlevered Free Cash Flow
7.332.612.522.925.82
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.